Cargando…

Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?

SIMPLE SUMMARY: Brain cancers are a devastating disease with no cure. The aim of the study was to determine whether in vitro models can replace in vivo models to assess the brain permeability of novel drugs for brain cancer. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Prashanth, Archana, Donaghy, Heather, Stoner, Shihani P., Hudson, Amanda L., Wheeler, Helen R., Diakos, Connie I., Howell, Viive M., Grau, Georges E., McKelvey, Kelly J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956470/
https://www.ncbi.nlm.nih.gov/pubmed/33668807
http://dx.doi.org/10.3390/cancers13050955
_version_ 1783664442885537792
author Prashanth, Archana
Donaghy, Heather
Stoner, Shihani P.
Hudson, Amanda L.
Wheeler, Helen R.
Diakos, Connie I.
Howell, Viive M.
Grau, Georges E.
McKelvey, Kelly J.
author_facet Prashanth, Archana
Donaghy, Heather
Stoner, Shihani P.
Hudson, Amanda L.
Wheeler, Helen R.
Diakos, Connie I.
Howell, Viive M.
Grau, Georges E.
McKelvey, Kelly J.
author_sort Prashanth, Archana
collection PubMed
description SIMPLE SUMMARY: Brain cancers are a devastating disease with no cure. The aim of the study was to determine whether in vitro models can replace in vivo models to assess the brain permeability of novel drugs for brain cancer. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, our systematic review reveals that microfluidic-based in vitro models comprising stem cell-derived endothelial cells, and primary astrocytes, pericytes and neurons can, in part, replicate the physiological ability of in vivo models to mimic patient permeability data. This information will guide the development and use of in vitro models for novel therapeutics of unknown permeability for brain cancer. ABSTRACT: Background: High grade gliomas (HGG) are incapacitating and prematurely fatal diseases. To overcome the poor prognosis, novel therapies must overcome the selective and restricted permeability of the blood–brain barrier (BBB). This study critically evaluated whether in vitro human normal BBB and tumor BBB (BBTB) are suitable alternatives to “gold standard” in vivo models to determine brain permeability. Methods: A systematic review utilizing the PRISMA guidelines used English and full-text articles from the past 5 years in the PubMed, Embase, Medline and Scopus databases. Experimental studies employing human cell lines were included. Results: Of 1335 articles, the search identified 24 articles for evaluation after duplicates were removed. Eight in vitro and five in vivo models were identified with the advantages and disadvantages compared within and between models, and against patient clinical data where available. The greatest in vitro barrier integrity and stability, comparable to in vivo and clinical permeability data, were achieved in the presence of all cell types of the neurovascular unit: endothelial cells, astrocytes/glioma cells, pericytes and neurons. Conclusions: In vitro co-culture BBB models utilizing stem cell-derived or primary cells are a suitable proxy for brain permeability studies in order to reduce animal use in medical research.
format Online
Article
Text
id pubmed-7956470
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79564702021-03-16 Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics? Prashanth, Archana Donaghy, Heather Stoner, Shihani P. Hudson, Amanda L. Wheeler, Helen R. Diakos, Connie I. Howell, Viive M. Grau, Georges E. McKelvey, Kelly J. Cancers (Basel) Systematic Review SIMPLE SUMMARY: Brain cancers are a devastating disease with no cure. The aim of the study was to determine whether in vitro models can replace in vivo models to assess the brain permeability of novel drugs for brain cancer. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, our systematic review reveals that microfluidic-based in vitro models comprising stem cell-derived endothelial cells, and primary astrocytes, pericytes and neurons can, in part, replicate the physiological ability of in vivo models to mimic patient permeability data. This information will guide the development and use of in vitro models for novel therapeutics of unknown permeability for brain cancer. ABSTRACT: Background: High grade gliomas (HGG) are incapacitating and prematurely fatal diseases. To overcome the poor prognosis, novel therapies must overcome the selective and restricted permeability of the blood–brain barrier (BBB). This study critically evaluated whether in vitro human normal BBB and tumor BBB (BBTB) are suitable alternatives to “gold standard” in vivo models to determine brain permeability. Methods: A systematic review utilizing the PRISMA guidelines used English and full-text articles from the past 5 years in the PubMed, Embase, Medline and Scopus databases. Experimental studies employing human cell lines were included. Results: Of 1335 articles, the search identified 24 articles for evaluation after duplicates were removed. Eight in vitro and five in vivo models were identified with the advantages and disadvantages compared within and between models, and against patient clinical data where available. The greatest in vitro barrier integrity and stability, comparable to in vivo and clinical permeability data, were achieved in the presence of all cell types of the neurovascular unit: endothelial cells, astrocytes/glioma cells, pericytes and neurons. Conclusions: In vitro co-culture BBB models utilizing stem cell-derived or primary cells are a suitable proxy for brain permeability studies in order to reduce animal use in medical research. MDPI 2021-02-25 /pmc/articles/PMC7956470/ /pubmed/33668807 http://dx.doi.org/10.3390/cancers13050955 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Prashanth, Archana
Donaghy, Heather
Stoner, Shihani P.
Hudson, Amanda L.
Wheeler, Helen R.
Diakos, Connie I.
Howell, Viive M.
Grau, Georges E.
McKelvey, Kelly J.
Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?
title Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?
title_full Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?
title_fullStr Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?
title_full_unstemmed Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?
title_short Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?
title_sort are in vitro human blood–brain–tumor-barriers suitable replacements for in vivo models of brain permeability for novel therapeutics?
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956470/
https://www.ncbi.nlm.nih.gov/pubmed/33668807
http://dx.doi.org/10.3390/cancers13050955
work_keys_str_mv AT prashantharchana areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics
AT donaghyheather areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics
AT stonershihanip areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics
AT hudsonamandal areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics
AT wheelerhelenr areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics
AT diakosconniei areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics
AT howellviivem areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics
AT graugeorgese areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics
AT mckelveykellyj areinvitrohumanbloodbraintumorbarrierssuitablereplacementsforinvivomodelsofbrainpermeabilityfornoveltherapeutics